Reinke, E.N.; Petersen, E.J.; Gordon, J.D.; Uhl, R.; Adams, V.H.; Rua, D.; Johnson, V.J.; Burleson, G.R.; Strickland, J.; Gutierrez, R.;
et al. Validation of the Electrophilic Allergen Screening Assay for Detection of Key Event 1 of the Skin Sensitization Adverse Outcome Pathway. Toxics 2026, 14, 511.
https://doi.org/10.3390/toxics14060511
AMA Style
Reinke EN, Petersen EJ, Gordon JD, Uhl R, Adams VH, Rua D, Johnson VJ, Burleson GR, Strickland J, Gutierrez R,
et al. Validation of the Electrophilic Allergen Screening Assay for Detection of Key Event 1 of the Skin Sensitization Adverse Outcome Pathway. Toxics. 2026; 14(6):511.
https://doi.org/10.3390/toxics14060511
Chicago/Turabian Style
Reinke, Emily N., Elijah J. Petersen, John D. Gordon, Rick Uhl, Valerie H. Adams, Diego Rua, Victor J. Johnson, Gary R. Burleson, Judy Strickland, Robert Gutierrez,
and et al. 2026. "Validation of the Electrophilic Allergen Screening Assay for Detection of Key Event 1 of the Skin Sensitization Adverse Outcome Pathway" Toxics 14, no. 6: 511.
https://doi.org/10.3390/toxics14060511
APA Style
Reinke, E. N., Petersen, E. J., Gordon, J. D., Uhl, R., Adams, V. H., Rua, D., Johnson, V. J., Burleson, G. R., Strickland, J., Gutierrez, R., Sprankle, C. S., LaPratt, T., Lehmann, D. M., Germolec, D. R., & Kleinstreuer, N. C.
(2026). Validation of the Electrophilic Allergen Screening Assay for Detection of Key Event 1 of the Skin Sensitization Adverse Outcome Pathway. Toxics, 14(6), 511.
https://doi.org/10.3390/toxics14060511
